Catalyst Pharmaceuticals (CPRX) Change in Inventory (2019 - 2026)

Catalyst Pharmaceuticals has reported Change in Inventory for 8 years, with the latest figure at -$2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 1043.46% year-over-year to -$2.2 million; the trailing twelve-month figure through Mar 2026 stood at $15.6 million (up 9023.43% YoY), and the FY2025 full-year result was $18.1 million, up 364.18% from the prior year.
• Change in Inventory for Q1 2026 stood at -$2.2 million, down from $9.2 million in the prior quarter.
• The five-year high for Change in Inventory was $9.2 million in Q4 2025, with the low at -$2.2 million in Q1 2026.
• Historically, Change in Inventory has averaged $1.4 million across 5 years, with a median of -$43000.0 in 2022.
• The largest YoY upside for Change in Inventory was 2121.1% in 2023 against a maximum downside of 1241.86% in 2023.
• Catalyst Pharmaceuticals' Change in Inventory stood at -$327000.0 in 2022, then surged by 2121.1% to $6.6 million in 2023, then sank by 107.2% to -$476000.0 in 2024, then soared by 2036.97% to $9.2 million in 2025, then plunged by 124.25% to -$2.2 million in 2026.
• The last three Change in Inventory figures came in at -$2.2 million (Q1 2026), $9.2 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.